Velocity Pharmaceutical Development (VPD) was formed by CMEA Capital to make majority ownership, controlling purchases of drug candidates and to develop these candidates using a cost-efficient “build to sell” model. VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party. VPD designs and executes the clinical development program for each of these drug candidates.
Location: United States, California, South San Francisco
Phone: +1 650-745-8179
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Presidio P... | presidiopa... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 02.06.2015 | Bristol-My... | LIFE SCIENCE A team of resear... | - | - | medcitynew... |
| 21.01.2013 | Pharma lic... | “The EuMederis model of rapid ... | - | - | medcitynew... |
| - | Bristol-My... | TOP STORIES The venture arm o... | - | - | medcitynew... |
| - | Pharma lic... | A licensing deal between two C... | - | - | medcitynew... |